Business News
Financial news, mergers and acquisitions, partnerships, and alliances.
Freenome Raises $300M in Series D Financing
The company will use the funding to support commercialization of its blood-based colorectal cancer detection test and to fuel expansion to other tumor types.
NGM Biopharmaceuticals, Merck to Study ILT2/4 Inhibitor Plus Keytruda in Solid Tumors
The companies inked a collaboration to study the drug combination in advanced solid tumors with elevated expression of ILT2 and ILT4.
Redx Pharma, Caris Life Sciences Partner for Colorectal Cancer Phase II Drug Study Recruitment
The pharma firm is using Caris’ comprehensive molecular profiling to help advance its investigational Porcupine inhibitor, RXC004, in the US.
OrigiMed, Janssen Partner to Improve Precision Cancer Medicine Development, Access in China
The companies will establish a real-world evidence database and use AI to identify new treatment indications and CDx development opportunities.
In Brief This Week: Orgenesis, Veracyte, Scorpion, Viracta, Tempus, Labcorp
News items for the week of Nov. 29, 2021.
Dec 2, 2021
Acepodia Raises $109M in Series C Financing
Nov 22, 2021
Cancer Dx Firms ACT Genomics, Sanomics Merge
Nov 12, 2021
AstraZeneca's Q3 Oncology Revenues Grow 18 Percent
Nov 9, 2021